Gaucher's disease natural history: Difference between revisions
Created page with "__NOTOC__ {{Gaucher's disease}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. {{CMG}}; '''As..." |
No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 14: | Line 14: | ||
* [[Anemia (patient information)|Anemia]] | * [[Anemia (patient information)|Anemia]] | ||
* [[Thrombocytopenia (patient information)|Thrombocytopenia]] | * [[Thrombocytopenia (patient information)|Thrombocytopenia]] | ||
* | * [[Osteopenia]] | ||
==Prognosis== | ==Prognosis== | ||
Line 20: | Line 20: | ||
Adults with the type 1 form of the disease can expect normal life expectancy with enzyme replacement therapy. | Adults with the type 1 form of the disease can expect normal life expectancy with enzyme replacement therapy. | ||
==References== | ==References== |
Latest revision as of 18:22, 31 August 2012
Gaucher's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Gaucher's disease natural history On the Web |
American Roentgen Ray Society Images of Gaucher's disease natural history |
Risk calculators and risk factors for Gaucher's disease natural history |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Natural History
Complications
Prognosis
How well a person does in Gaucher's disease depends on the subtype of the disease. The infantile form of Gaucher disease may lead to early death. Most affected children die before age 5.
Adults with the type 1 form of the disease can expect normal life expectancy with enzyme replacement therapy.